KIDS Earnings & Financial Statements
OrthoPediatrics Corp.
$22.87
+$0.61(+2.76%)
51
Overall
60
Value
40
Tech
55
Quality
Market Cap
$580.94M
Volume
14.85K
52W Range
$14.42 - $26.74
Target Price
$27.22
KIDS earnings and financial statements: OrthoPediatrics Corp.'s income statement, balance sheet and cash flow statement, annual and quarterly.
KIDS Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $236.35M | $204.73M | $148.73M | $122.29M | $98.05M |
| Cost of revenue | $63.69M | $56.13M | $37.48M | $31.63M | $24.65M |
| Operating income | -$39.24M | -$35.01M | -$26.75M | -$25.40M | -$18.02M |
| EBITDA | -$12.07M | -$20.23M | -$4.13M | $11.83M | -$7.19M |
| Net income | -$39.65M | -$37.82M | -$20.97M | $1.26M | -$16.26M |
| EPS (diluted) | $-1.69 | $-1.64 | $-0.92 | $0.06 | $-0.84 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $508.63M | $473.21M | $438.75M | $427.73M | $304.27M |
| Total liabilities | $162.03M | $118.64M | $61.72M | $49.08M | $78.91M |
| Shareholders’ equity | $346.60M | $354.57M | $377.02M | $378.65M | $225.37M |
| Cash and equivalents | $19.56M | $43.82M | $31.05M | $8.99M | $7.64M |
| Long-term debt | $51.35M | $48.55M | $152.0K | $907.0K | $1.04M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$4.85M | -$27.05M | -$27.05M | -$21.77M | -$13.06M |
| Capital expenditure | -$11.11M | -$14.26M | -$16.88M | -$10.03M | -$16.01M |
| Free cash flow | -$15.96M | -$41.31M | -$44.47M | -$31.80M | -$29.07M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KIDS | $22.87 | +2.8% | 14.85K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |